FDA recall D-1008-2020
Redline Pharmacy Solutions · Class II · drug
Product
Daptomycin, 500MG in 0.9% NACL 100ML Injectable Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
Reason for recall
Lack Of Processing Controls
Distribution
Sold to patients in Nebraska
Key facts
- Status
- Terminated
- Initiation date
- 2020-02-24
- Report date
- 2020-03-18
- Termination date
- 2022-03-31
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Hastings, NE, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1008-2020